Clinical Trials · NCT02685852
Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- University of Minnesota
- Enrollment
- 11
- Start date
- Feb 2016
- Locations
- 1 site, United States
- Primary endpoint
- Glucose area under the curve (AUC) following treatment for each 4-hour test period